LSTA · Categories · Form 4
LSTA - SEC Form 4 insider transactions
Lisata Therapeutics Inc. (LSTA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for LSTA
- President & CEO Mazzo David J was granted 81,000 shares and covered exercise/tax liability with 41,096 shares, increasing direct ownership by 15% to 311,890 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SVP, Fin/Treas, Chief Actg Off Nisco James was granted 15,000 shares and covered exercise/tax liability with 6,180 shares, increasing direct ownership by 38% to 32,311 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SVP, Bus Dev, General Counsel Imam Tariq covered exercise/tax liability with 3,501 shares and was granted 15,000 shares, increasing direct ownership by 47% to 36,078 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- EVP, R&D and CMO Buck Kristen K was granted 25,000 shares and covered exercise/tax liability with 11,332 shares, increasing direct ownership by 17% to 93,462 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Henson Heidi was granted 30,456 shares, increasing direct ownership by 55% to 85,725 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Klosk Steven M was granted 30,456 shares, increasing direct ownership by 47% to 95,815 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Flowers Cynthia Louise was granted 30,456 shares, increasing direct ownership by 47% to 95,446 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Brown Gregory B was granted 30,456 shares, increasing direct ownership by 47% to 95,659 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Azab Mohammad was granted 30,456 shares, increasing direct ownership by 41% to 104,925 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SVP, Fin/Treas, Chief Actg Off Nisco James covered exercise/tax liability with 4,465 shares and was granted 15,000 shares, increasing direct ownership by 81% to 23,491 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- EVP, R&D and CMO Buck Kristen K was granted 25,000 shares and covered exercise/tax liability with 7,878 shares, increasing direct ownership by 27% to 79,794 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- President & CEO Mazzo David J was granted 81,000 shares and covered exercise/tax liability with 30,462 shares, increasing direct ownership by 24% to 264,690 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Klosk Steven M was granted 15,789 shares, increasing direct ownership by 32% to 65,359 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Brown Gregory B was granted 15,789 shares, increasing direct ownership by 32% to 65,203 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Henson Heidi was granted 15,789 shares, increasing direct ownership by 40% to 55,269 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Flowers Cynthia Louise was granted 15,789 shares, increasing direct ownership by 32% to 64,990 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Director Azab Mohammad was granted 15,789 shares, increasing direct ownership by 27% to 74,469 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- EVP, R&D and CMO Buck Kristen K was granted 15,000 shares and covered exercise/tax liability with 6,363 shares, increasing direct ownership by 16% to 62,672 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SVP, Fin/Treas, Chief Actg Off Nisco James was granted 3,300 shares and covered exercise/tax liability with 1,701 shares, increasing direct ownership by 14% to 12,956 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- President & CEO Mazzo David J was granted 58,000 shares and covered exercise/tax liability with 26,964 shares, increasing direct ownership by 17% to 211,834 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Mazzo David J covered exercise/tax liability with 1,026 shares, decreasing direct ownership by 0.58% to 174,766 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Buck Kristen K was granted 27,000 shares and covered exercise/tax liability with 5,880 shares, increasing direct ownership by 64% to 54,035 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Mazzo David J was granted 94,000 shares and covered exercise/tax liability with 23,516 shares, increasing direct ownership by 67% to 175,792 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Klosk Steven M was granted 19,480 shares, increasing direct ownership by 65% to 49,570 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Henson Heidi was granted 19,480 shares, increasing direct ownership by 97% to 39,480 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Flowers Cynthia Louise was granted 19,480 shares, increasing direct ownership by 66% to 49,201 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Brown Gregory B was granted 19,480 shares, increasing direct ownership by 65% to 49,414 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- Azab Mohammad was granted 19,480 shares, increasing direct ownership by 50% to 58,680 units (SEC Form 4)4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Buck Kristen K covered exercise/tax liability with 2,908 shares, decreasing direct ownership by 8% to 32,915 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)